Entero Therapeutics, Correlations

ENTO Stock

0.40 0.02 4.76%

The current 90-days correlation between Entero Therapeutics, and Equillium is 0.1 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entero Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entero Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Entero Therapeutics, Correlation With Market

Good diversification

The correlation between Entero Therapeutics, and DJI is -0.18 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entero Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.

Moving together with Entero Stock

0.74	VANI	Vivani Medical	Pair Corr
0.92	DOMH	Dominari Holdings	Pair Corr
0.76	DRMA	Dermata Therapeutics	Pair Corr
0.74	CDIOW	Cardio Diagnostics	Pair Corr
0.78	DTIL	Precision BioSciences	Pair Corr
0.79	VIRX	Viracta Therapeutics	Pair Corr
0.92	DYAI	Dyadic International	Pair Corr
0.75	SRZNW	Surrozen Warrant	Pair Corr
0.76	VRCA	Verrica Pharmaceuticals	Pair Corr
0.72	CDTTW	Conduit Pharmaceuticals Symbol Change	Pair Corr
0.85	VSTM	Verastem	Pair Corr

Moving against Entero Stock

0.82	DMAC	DiaMedica Therapeutics	Pair Corr
0.81	DNTH	Dianthus Therapeutics Symbol Change	Pair Corr
0.73	VCYT	Veracyte	Pair Corr
0.67	DNLI	Denali Therapeutics	Pair Corr
0.52	VAXX	Vaxxinity	Pair Corr
0.48	VCEL	Vericel Corp Ord	Pair Corr
0.46	KA	Kineta Inc	Pair Corr
0.89	VRNA	Verona Pharma PLC	Pair Corr
0.73	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.39	VKTX	Viking Therapeutics	Pair Corr
0.39	VRAX	Virax Biolabs Group	Pair Corr
0.33	VRPX	Virpax Pharmaceuticals	Pair Corr

Related Correlations Analysis

	EQ	KA	DMAC	VALN	VANI	DNLI	DNTH	DOMH	VCEL	VCNX
EQ		0.06	0.49	0.5	0.33	0.37	0.04	-0.07	0.48	0.01	EQ
KA	0.06		0.4	-0.26	-0.5	0.44	0.6	-0.37	0.56	-0.04	KA
DMAC	0.49	0.4		-0.12	-0.39	0.77	0.66	-0.75	0.71	-0.39	DMAC
VALN	0.5	-0.26	-0.12		0.79	-0.1	-0.43	0.38	-0.06	0.21	VALN
VANI	0.33	-0.5	-0.39	0.79		-0.34	-0.61	0.66	-0.29	0.42	VANI
DNLI	0.37	0.44	0.77	-0.1	-0.34		0.65	-0.65	0.69	-0.32	DNLI
DNTH	0.04	0.6	0.66	-0.43	-0.61	0.65		-0.66	0.53	-0.31	DNTH
DOMH	-0.07	-0.37	-0.75	0.38	0.66	-0.65	-0.66		-0.41	0.71	DOMH
VCEL	0.48	0.56	0.71	-0.06	-0.29	0.69	0.53	-0.41		0.08	VCEL
VCNX	0.01	-0.04	-0.39	0.21	0.42	-0.32	-0.31	0.71	0.08		VCNX
	EQ	KA	DMAC	VALN	VANI	DNLI	DNTH	DOMH	VCEL	VCNX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VANI	+ 0.79	VALN
DNLI	+ 0.77	DMAC
VCEL	+ 0.71	DMAC
VCNX	+ 0.71	DOMH
VCEL	+ 0.69	DNLI
DNTH	+ 0.66	DMAC

High negative correlations

DOMH	- 0.75	DMAC
DOMH	- 0.66	DNTH
DOMH	- 0.65	DNLI
DNTH	- 0.61	VANI
VANI	- 0.5	KA
DNTH	- 0.43	VALN

Risk-Adjusted Indicators

There is a big difference between Entero Stock performing well and Entero Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Entero Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EQ	4.81	(0.52)	0.00	(0.17)	0.00	0.00	11.27	(11.11)	27.89
KA	5.99	0.75	0.11	0.61	6.10	(8.19)	14.29	(8.43)	66.77
DMAC	3.50	0.56	0.12	(1.22)	3.43	(4.13)	7.38	(5.51)	40.11
VALN	2.48	(0.44)	0.00	(0.23)	0.00	0.00	4.56	(5.13)	19.77
VANI	1.88	(0.51)	0.00	(0.48)	0.00	0.00	4.07	(6.02)	14.73
DNLI	2.46	0.24	0.10	0.23	2.64	(2.61)	5.71	(5.21)	15.90
DNTH	3.22	0.37	0.10	0.43	3.42	(3.53)	7.67	(5.94)	20.60
DOMH	2.17	(0.40)	0.00	(1.20)	0.00	0.00	3.82	(6.02)	12.13
VCEL	2.04	(0.08)	(0.01)	0.03	2.17	(2.38)	3.98	(3.12)	14.65
VCNX	5.09	(0.08)	0.00	0.29	0.00	0.00	9.94	(6.67)	64.11

Entero Therapeutics, Corporate Management

Jennifer SealeyVoyksner	Senior Development	Profile
Sarah CPA	Chief Officer	Profile
Amy ChandlerSkerkis	QA Affairs	Profile
Martin MBA	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC